These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17417789)

  • 1. Precursor natural killer cell leukemia.
    Liang X; Greffe B; Garrington T; Graham DK
    Pediatr Blood Cancer; 2008 Apr; 50(4):876-8. PubMed ID: 17417789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell neoplasms.
    Liang X; Graham DK
    Cancer; 2008 Apr; 112(7):1425-36. PubMed ID: 18286525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive natural killer cell leukemia: clinical features and treatment outcome.
    Song SY; Kim WS; Ko YH; Kim K; Lee MH; Park K
    Haematologica; 2002 Dec; 87(12):1343-5. PubMed ID: 12495907
    [No Abstract]   [Full Text] [Related]  

  • 4. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
    Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
    Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis.
    Ogura K; Kimura F; Kobayashi S; Torikai H; Ikeda T; Sato K; Motoyoshi K
    Leuk Res; 2006 Jun; 30(6):761-3. PubMed ID: 16140376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of the art in natural killer cell malignancies.
    Semenzato G; Marino F; Zambello R
    Int J Lab Hematol; 2012 Apr; 34(2):117-28. PubMed ID: 21895989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of cutaneous blastic NK lymphoma in a 32-year-old Korean woman.
    Chang SE; Choi HJ; Huh J; Choi JH; Moon KC; Koh JK
    Int J Dermatol; 2006 May; 45(5):591-3. PubMed ID: 16700799
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment for NK-cell lymphoma].
    Yamaguchi M
    Rinsho Ketsueki; 2004 Mar; 45(3):209-17. PubMed ID: 15103934
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blastic natural killer cell leukemia--one case report and review of literature].
    Guo XN; Wang CY; Wang Y; Xu SR; Ren JH; Lin FR; Yao EG
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):362-4. PubMed ID: 12941191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Hsp70 peptide initiates NK cell killing of leukemic blasts after stem cell transplantation.
    Gross C; Holler E; Stangl S; Dickinson A; Pockley AG; Asea AA; Mallappa N; Multhoff G
    Leuk Res; 2008 Apr; 32(4):527-34. PubMed ID: 17543383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic characterization of natural killer cell leukemia.
    Yonescu R; Hristov AC; Ahmad A; Overby A; Thomas GH; Griffin CA
    Cancer Genet Cytogenet; 2008 Jun; 183(2):125-30. PubMed ID: 18503833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
    Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
    Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged treatment response in aggressive natural killer cell leukemia.
    Osuji N; Matutes E; Morilla A; Del Giudice I; Wotherspoon A; Catovsky D
    Leuk Lymphoma; 2005 May; 46(5):757-63. PubMed ID: 16019515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in understanding and managing natural killer-cell malignancies.
    Oshimi K
    Br J Haematol; 2007 Nov; 139(4):532-44. PubMed ID: 17916099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells.
    Okuno SH; Tefferi A; Hanson CA; Katzmann JA; Li CY; Witzig TE
    Br J Haematol; 1996 Jun; 93(4):810-2. PubMed ID: 8703808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases.
    Karube K; Aoki R; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Sugita Y; Ohshima K
    Pathol Int; 2008 Feb; 58(2):89-97. PubMed ID: 18199158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic transplantation and leukemia: a second chance for T cells?
    Kuppen PJ
    Transplantation; 2008 Jan; 85(1):7-8. PubMed ID: 18192904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.